Glucagon Global Market 2018: Key Players – Novo Nordisk, Eli Lilly, Fresenius Kabi, Torrent Labs, Taj Pharmaceuticals

Glucagon Industry

Description

Wiseguyreports.Com Adds “Glucagon -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2023” To Its Research Database

This report studies the Glucagon market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Glucagon market by product type and applications/end industries.

In the last several years, global market of glucagon developed rapidly, with an average growth rate of 5.40%. In 2017, global revenue of glucagon is nearly 434 M USD; the actual consumption is about 24.2 million units.

The major players in global Glucagon market include

Novo Nordisk 
Eli Lilly 
Fresenius Kabi 
Torrent Labs 
Taj Pharmaceuticals 
Xeris Pharmaceuticals

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/3254943-global-glucagon-market-research-report-2018

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth rate (%) of glucagon in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
Asia-Pacific
South America
Middle East and Africa

On the basis of product, the Glucagon market is primarily split into
Inject Glucagon
Nasal Glucagon

On the basis on the end users/applications, this report covers
Emergency Kits
General Use
Diagnostic & Motility
Cardiogenic Shock
Others

Leave a Query @ https://www.wiseguyreports.com/enquiry/3254943-global-glucagon-market-research-report-2018

 

Table of Contents

1 Glucagon Market Overview 1
1.1 Glucagon Product Overview 1
1.2 Glucagon Segment by Types (Product Category) 2
1.2.1 Global Glucagon Sales and Growth (%) Comparison by Types (2013-2025) 2
1.2.2 Inject Glucagon 2
1.2.3 Nasal Glucagon 3
1.3 Global Glucagon Segment by Applications 3
1.3.1 Global Glucagon Sales Comparison by Applications (2013-2025) 3
1.3.2 Hypoglycemia 4
1.3.3 Cardiogenic Shock 5
1.4 Global Glucagon Market by Regions (2013-2025) 6
1.4.1 Global Glucagon Market Size and Growth Rate Comparison by Regions (2013-2025) 6
1.4.2 North America Glucagon Status and Prospect (2013-2025) 7
1.4.3 Europe Glucagon Status and Prospect (2013-2025) 8
1.4.4 Asia-Pacific Glucagon Status and Prospect (2013-2025) 9
1.4.5 South America Glucagon Status and Prospect (2013-2025) 10
1.4.6 Middle East and Africa Glucagon Status and Prospect (2013-2025) 11
1.5 Global Glucagon Market Size (2013-2025) 12
1.5.1 Global Glucagon Revenue Status and Outlook (2013-2025) 12
1.5.2 Global Glucagon Sales Status and Outlook (2013-2025) 13

....

6 Analysis of Glucagon Industry Key Manufacturers 38
6.1 Novo Nordisk 38
6.1.1 Company Profile 38
6.1.2 Product Information 39
6.1.3 Sales, Price, Cost, Gross, and Revenue 39
6.2 Eli Lilly 40
6.2.1 Company Profile 40
6.2.2 Product Information 41
6.2.3 Sales, Price, Cost, Gross, and Revenue 41
6.3 Fresenius Kabi 42
6.3.1 Company Profile 42
6.3.2 Product Information 43
6.3.3 Sales, Price, Cost, Gross, and Revenue 43
6.4 Torrent Pharma 44
6.4.1 Company Profile 44
6.4.2 Product Information 45
6.4.3 Sales, Price, Cost, Gross, and Revenue 45
6.5 Taj Pharmaceuticals 46
6.6 Xeris Pharmaceuticals 47
6.6.1 Company Profile 47
6.6.2 Product Information 48
7 Glucagon Manufacturing Cost Analysis 49
7.1 Glucagon Key Component Analysis 49
7.1.1 Key Component 49
7.1.2 Key Suppliers of Raw Materials 49
7.2 Proportion of Manufacturing Cost Structure 51
7.2.1 Raw Materials 51
7.2.2 Labor Cost 51
7.2.3 Other Costs Analysis 58
7.2.4 Manufacturing Expenses 62

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=3254943

Continued...                       

 

Contact Us: [email protected] Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

 

 

Posted by on Tuesday July 31 2018, 11:00 AM EST. All trademarks acknowledged. Filed under Uncategorized. Comments and Trackbacks closed. Follow responses: RSS 2.0

Comments are closed

Featured Press Releases

Log in